AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ambroglim M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Ambroza Lifecare LLP

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Ambroglim M 1mg/500mg Tablet

Diabetacomb MX tablets (1mg/500mg) are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabetacomb MX should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended by your doctor.

Primary Ingredients of Ambroglim M 1mg/500mg Tablet

No text provided to rephrase.

Uses of Ambroglim M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Ambroglim M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Ambroglim M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Ambroglim M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ambroglim M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Ambroglim M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.

How Ambroglim M 1mg/500mg Tablet works:

Ambroglim M tablets (1mg/500mg) combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Ambroglim M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ambroglim M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

The medication Ambroglim M 1mg/500mg tablets is contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this drug.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ambroglim M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Ambroglim M 1mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Ambroglim M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. In those with mild to moderate liver disease, a low initial dose is typically recommended, while use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Ambroglim M 1mg/500mg Tablet :

Should you forget to take your Ambroglim M 1mg/500mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ambroglim M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Ambroglim M 1mg/500mg Tablet

Maintain this medication within its original, securely sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Ambroglim M 1mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia warrant immediate discontinuation of Ambroglim M 1mg/500mg Tablets and prompt medical attention.
Ambroglim M 1mg/500mg tablets contain glimepiride and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This treatment enhances blood sugar control when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin release from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. This combination therapy is unsuitable for treating type 1 diabetes.
Ambroglim M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis have also been reported. Prolonged use might result in vitamin B12 deficiency.
Prolonged use of Ambroglim M 1mg/500mg Tablets can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, as proposed by some studies, include annual supplementation of Vitamin B12.
Indeed, Ambroglim M 1mg/500mg tablets may induce hypoglycemia. Manifestations of low blood sugar include nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol concurrently with Ambroglim M 1mg/500mg Tablet is unsafe due to the potential for dangerously low blood sugar (hypoglycemia) and a heightened risk of lactic acidosis.
Ambroglim M 1mg/500mg Tab...
66
MRP 80
17% off